Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Bile Duct Diseases

fluorodeoxyglucose f18 has been researched along with Bile Duct Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kimura, N; Miki, A; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Wakabayashi, H; Yamamoto, Y	1
Barthel, H; Berr, F; Caca, K; Georgi, P; Hesse, S; Huster, D; Kluge, R; Schmidt, F; Seese, A	1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Bile Duct Diseases

Article	Year
Comparison of early and delayed FDG PET for evaluation of biliary stricture. Nuclear medicine communications, 2007, Volume: 28, Issue:12 Topics: Aged; Aged, 80 and over; Bile Duct Diseases; Biliary Tract Neoplasms; Constriction, Pathologic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors	2007
Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology (Baltimore, Md.), 2001, Volume: 33, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Diseases; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Radiography; Radiopharmaceuticals; Reference Values; ROC Curve; Tomography, Emission-Computed	2001

Article

Year

Comparison of early and delayed FDG PET for evaluation of biliary stricture.

Nuclear medicine communications, 2007, Volume: 28, Issue:12

Topics: Aged; Aged, 80 and over; Bile Duct Diseases; Biliary Tract Neoplasms; Constriction, Pathologic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors

2007

Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.

Hepatology (Baltimore, Md.), 2001, Volume: 33, Issue:5

Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Diseases; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Radiography; Radiopharmaceuticals; Reference Values; ROC Curve; Tomography, Emission-Computed

2001